David Stroud
banner
dstroudlab.bsky.social
David Stroud
@dstroudlab.bsky.social
Functional Genomics | Clinical Proteomics | Rare Disease
We noticed CII assembly factor SDHAF2 accumulates in some OXPHOS deficient cell lines but not others. New Dr Kugan cracked the case: CII assembly controls a balance btwn TCA cycle direction and protection from Q-pool stress to support ROS-meditated metabolic reprogramming in OXPHOS adapted cells.
Complex II assembly drives metabolic adaptation to OXPHOS dysfunction
Succinate dehydrogenase assembly dynamics maintains metabolic homeostasis during mitochondrial oxidative stress.
www.science.org
August 15, 2025 at 9:16 PM
Reposted by David Stroud
Dr Dani Hock from @dstroudlab.bsky.social
presenting on #RDMassSpec in diagnosis of #raredisease in the Multiomics session #ESHG2025
May 26, 2025 at 9:52 AM
We're super proud to see our study showing utility of proteomics in ultra-rapid variant prioritisation for suspected mito and other rare diseases out in Genome Medicine (rdcu.be/endwE). Too many amazing collabs to thank, so here are the big ones @daniellahock.bsky.social @thorburnmito.bsky.social!
Cutting the diagnosis journey for children born with rare genetic diseases
Families can wait years for a diagnosis of a rare genetic disorder, but a new test can provide answers in days for a better understanding of the condition and potentially earlier treatment, finds new...
pursuit.unimelb.edu.au
May 23, 2025 at 12:57 AM